Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience. [electronic resource]
Producer: 20060209Description: 717-22 p. digitalISSN:- 0284-186X
- Adenocarcinoma -- drug therapy
- Adenocarcinoma, Bronchiolo-Alveolar -- drug therapy
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Female
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Quinazolines -- therapeutic use
- Retrospective Studies
- Safety
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.